• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Immunoglobulin superfamily member 5 (IGSF5), Truncated

ACP10267

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP10267 Target NameIGSF5
Target SynonymsIGSF5; JAM4; Immunoglobulin superfamily member 5; IgSF5; Junctional adhesion molecule 4; JAM-4FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Protein LengthPartial
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ9NSI5
Background Information
  • Uniprot Id

    Q9NSI5

  • Target Species

    Human

  • Target Name

    IGSF5

  • Target Full Name

    Immunoglobulin superfamily member 5

  • Target Function

    Provides, together with MAGI1, an adhesion machinery at tight junctions, which may regulate the permeability of kidney glomerulus and small intestinal epithelial cells. Mediates calcium-independent homophilic cell adhesion. In testis, it may function as a cell adhesion molecule rather than a tight-junction protein. It may participate in the adhesion between spermatogonia-spermatogonia, spermatogonia-Sertoli cells, and Sertoli cells-Sertoli cells.

  • Target Subcellular Location

    Apical cell membrane; Single-pass type I membrane protein. Cell junction, tight junction.

  • Target Protein Families

    Immunoglobulin superfamily

  • Target Synonyms

    IGSF5; JAM4; Immunoglobulin superfamily member 5; IgSF5; Junctional adhesion molecule 4; JAM-4

Inquire Recombinant Human Immunoglobulin superfamily member 5 (IGSF5), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification